Clinical Trials Directory

Trials / Sponsors / Ensysce Biosciences

Ensysce Biosciences

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingPF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Postoperative Pain, Acute
Phase 32025-12-09
RecruitingSingle Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
Pharmacokinetics
Phase 12024-11-24
CompletedAssessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
Acute Pain
Phase 22023-10-05
CompletedA Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)
Recreational Drug Use
Phase 12022-10-05
CompletedA Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-
Recreational Drug Use
Phase 12022-06-10
CompletedPharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101)
Pharmacokinetics
Phase 12021-12-01
CompletedEvaluation of Oral PF614 Relative to OxyContin (PF614-102)
Healthy Volunteers
Phase 12021-09-08
CompletedOral Nafamostat in Healthy Volunteers (NAF-101)
Pharmacokinetics
Phase 12020-09-21
CompletedStudy of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)
Healthy
Phase 12016-11-16